Journal of Heterocyclic Chemistry p. 229 - 239 (2000)
Update date:2022-08-05
Topics:
Grozinger, Karl G.
Byrne, Denis P.
Nummy, Laurence J.
Ridges, Michael D.
Salvagno, Annette
Nevirapine (1) is a non-nucleoside reverse transcriptase inhibitor marketed for HIV treatment by Boehringer Ingelheim as Viramune since 1996. In vitro studies of nevirapine biotransformation using human liver microsomes demonstrated the formation of five major metabolites. This paper describes the syntheses of these metabolites.
View MoreBeijing Greenchem Technology Co.,Ltd. ( Panjin Greenchem Technology Co.Ltd .)
website:http://www.bjgreenchem.com/
Contact:+86-427-6515887
Address:301,302, 3rd Floor, Building C-7, Dongsheng Science Park, Northern Territory, Zhongguancun, No. 66, Xixiaokou Road, Haidian District, Beijing
Nanjing Chemical Material Corp.(NCMC)
website:http://www.njchemm.com
Contact:0086-25-83172879
Address:B12 Technology and Innovation Building, Nanjing Tech University, No.5 New Model Road
HANGZHOU ZHONGCHANG SCIENTIFIC CO.,LTD
Contact:+86-571-88932183
Address:Hangzhou
shijiazhuang baisheng chem co.; ltd
Contact:86-0311-80790826
Address:shijiazhuang hebei
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
Doi:10.1016/j.tet.2017.02.061
(2017)Doi:10.1016/S0040-4020(03)00770-1
(2003)Doi:10.1039/b000600i
(2000)Doi:10.1016/j.catcom.2010.02.007
(2010)Doi:10.1039/b807704e
(2008)Doi:10.1002/1521-3765(20010601)7:11<2332::AID-CHEM23320>3.0.CO;2-W
(2001)
